SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001178913-20-001787
Filing Date
2020-06-15
Accepted
2020-06-15 06:13:09
Documents
198
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 20-F zk2024554.htm 20-F 5994496
2 EXHIBIT 12.1 exhibit_12-1.htm EX-12.1 7448
3 EXHIBIT 12.2 exhibit_12-2.htm EX-12.2 7910
4 EXHIBIT 13.1 exhibit_13-1.htm EX-13.1 5043
5 EXHIBIT 13.2 exhibit_13-2.htm EX-13.2 5174
6 EXHIBIT 15.1 exhibit_15-1.htm EX-15.1 6313
  Complete submission text file 0001178913-20-001787.txt   32825054

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT trib-20191231.xml EX-101.INS 10785882
8 XBRL TAXONOMY EXTENSION SCHEMA trib-20191231.xsd EX-101.SCH 198075
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE trib-20191231_cal.xml EX-101.CAL 193726
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE trib-20191231_def.xml EX-101.DEF 627237
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE trib-20191231_lab.xml EX-101.LAB 1027878
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE trib-20191231_pre.xml EX-101.PRE 888505
Mailing Address 3 ROCK ROAD SANDYFORD INDUSTRIAL ESTATES DUBLIN IRELAND L2 18
Business Address IDA BUSINESS PARK, BRAY, CO WICKLOW IRELAND DUBLIN IRELAND L2 18 01135312955111
TRINITY BIOTECH PLC (Filer) CIK: 0000888721 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 000-22320 | Film No.: 20961845
SIC: 2835 In Vitro & In Vivo Diagnostic Substances